ConvaTec is struggling to overcome operational problems, but its moat remains narrow.
ConvaTec posted first-half results, with the ostomy segment outpacing our expectations, but this was offset by advanced wound-care results that fell slightly short due to near-term manufacturing bumps. Because timing differences do not usually make a material difference in our valuation, we do not expect any changes to our fair value estimate. Thanks to the highly consolidated nature of the ostomy market, we think ConvaTec has a strong shot at reviving growth in that segment once it executes bet...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.